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Abstract
Objectives: The intestinal epithelium compartmentalizes the sterile bloodstream and the commensal bacteria in
the gut. Accumulating evidence suggests that this barrier is impaired in sepsis, aggravating systemic inflammation.
Previous studies reported that cathelicidin is differentially expressed in various tissues in sepsis. However, its role in
sepsis-induced intestinal barrier dysfunction has not been investigated.
Design: To examine the role of cathelicidin in polymicrobial sepsis, cathelicidin wild-(Cnlp+/+) and knockout
(Cnlp−/−) mice underwent cecal-ligation and puncture (CLP) followed by the assessment of septic mortality and
morbidity as well as histological, biochemical, immunological, and transcriptomic analyses in the ileal tissues. We
also evaluated the prophylactic and therapeutic efficacies of vitamin D3 (an inducer of endogenous cathelicidin) in
the CLP-induced murine polymicrobial sepsis model.
Results: The ileal expression of cathelicidin was increased by three-fold after CLP, peaking at 4 h. Knockout of Cnlp
significantly increased 7-day mortality and was associated with a higher murine sepsis score. Alcian-blue staining
revealed a reduced number of mucin-positive goblet cells, accompanied by reduced mucin expression. Increased
number of apoptotic cells and cleavage of caspase-3 were observed. Cnlp deletion increased intestinal permeability
to 4kD fluorescein-labeled dextran and reduced the expression of tight junction proteins claudin-1 and occludin.
Notably, circulating bacterial DNA load increased more than two-fold. Transcriptome analysis revealed upregulation
of cytokine/inflammatory pathway. Depletion of Cnlp induced more M1 macrophages and neutrophils compared
with the wild-type mice after CLP. Mice pre-treated with cholecalciferol (an inactive form of vitamin D3) or treated
with 1alpha, 25-dihydroxyvitamin D3 (an active form of VD3) had decreased 7-day mortality and significantly less
severe symptoms. Intriguingly, the administration of cholecalciferol after CLP led to worsened 7-day mortality and
the associated symptoms.
Conclusions: Endogenous cathelicidin promotes intestinal barrier integrity accompanied by modulating the
infiltration of neutrophils and macrophages in polymicrobial sepsis. Our data suggested that 1alpha, 25-dihydroxyvitamin
D3 but not cholecalciferol is a potential therapeutic agent for treating sepsis.
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Introduction
Sepsis is a life-threatening organ dysfunction accompan-
ied by systemic inflammation and immunosuppression
as a consequence of the host response to microbial in-
fections. Sepsis which carries high mortality and morbi-
dity in the intensive care unit remains a major health
burden [1]. Therefore, there is a compelling need for
developing novel sepsis therapies.
The pathogenesis of sepsis has been attributed, at
least in part, to the loss of intestinal epithelial barrier.
As the first line of defense, the gut intestinal epithe-
lial barrier impedes the translocation of commensal
bacteria from the gut lumen into the bloodstream.
Accumulating evidence suggests that the intestinal
barrier function is impaired during systemic inflam-
mation as in sepsis. These include epithelial apoptosis,
disruption of tight junctions leading to an increase in
intestinal permeability [2, 3]. The impaired gut barrier
function may increase the risk of bacterial transloca-
tion from the gut lumen to the bloodstream, aggra-
vating systemic inflammation. Clinically, bacterial
translocation from the gut into the bloodstream has
been demonstrated in patients with postoperative sep-
sis [4]. An abnormal and severe derangement of intes-
tinal permeability upon admission to an intensive care
unit was found to predict subsequent development of
multiple organ failure [5]. However, the underlying
mechanism of sepsis-associated gut barrier dysfunc-
tion remains elusive.
Cathelicidin represents one of the most important
classes of antimicrobial peptides in mammals. It has
bactericidal property, inhibits endotoxin-induced pyr-
optosis of leukocytes, suppresses the release of inflam-
matory mediators, and protects endothelial cells from
apoptosis [6, 7]. Cathelicidin can be induced by vita-
min D3 (VD3), which has therapeutic properties out-
side of its classic functions related to bone and
calcium homeostasis [8, 9]. In particular, a growing
body of evidence has shown the antibiotic-like prop-
erties of vitamin D [10]. Thus, this natural compound
may prove to be effective against sepsis, as an adjunct
treatment modality. Previously, Chen and his col-
leagues suggested that VD3 exerts protective effects
during infections by upregulating the expression of
cathelicidin and beta-defensin 2 in phagocytes and
epithelial cells [11]. Another study found that sys-
temic LL-37 (human cathelicidin) levels may be regu-
lated by VD3 status [12]. In our study, we aimed to
investigate the role of murine cathelicidin-related
antimicrobial peptide (mCRAMP), a rodent antimicro-
bial peptide analogous to human cathelicidin LL-37,
in maintaining gut barrier function in sepsis and to
explore the relationship between vitamin D3 status
and cathelicidin production in CLP mice model.
Materials and methods
Animals
129/SVJ wild-type (Cnlp+/+) and cathelicidin-knockout
(Cnlp−/−) mice were used. These mouse strains were
generated as previously described [13]. All animals were
male and 8 to 10 weeks old. They were maintained in
the Laboratory Animal Services Center of the Chinese
University of Hong Kong at a controlled temperature of
25 °C ± 1 °C, relative humidity 55% ± 5%. A cycle of 12 h
light/12 h dark was maintained prior to the experiments.
Cecal ligation and puncture
Polymicrobial sepsis was induced by cecal-ligation and
puncture (CLP) [14]. Under anesthesia with intra-
peritoneal injection of ketamine (75 mg/kg) and xylazine
(10 mg/kg), a 1-cm midline incision was made on the
anterior abdomen. The cecum was exposed and ligated
at 50% from the distal end. A through-and-through
puncture was performed with a 22-gauge needle to in-
duce sepsis. The cecum was then placed back into the
peritoneal cavity. Sham-operated animals underwent ab-
dominal incision and intestinal manipulation with nei-
ther ligation nor puncture. All animals were given 1ml
of normal saline by subcutaneous injection and placed
on a warm towel immediately after the surgery. The sur-
vival rates and septic severity were recorded every 12 h
until 7 days after the surgery. No antibiotic was given to
the CLP-operated mice in order to assess the systemic
inflammation after surgery [15, 16] Concerning animal
welfare, buprenorphine (0.01 mg/kg) was administered
to the mice after surgery. Mice were given buprenor-
phine (0.01 mg/kg) daily until the end of the experiment
if necessary.
VD3 prophylaxis
VD3 were purchased from Sigma Chemical Co. (St.,
Louis, MO). In the water control group, mice were pre-
treated with water by oral gavage at 48 h, 24 h, and 1 h
before CLP. In the VD3 prophylaxis group, mice were pre-
treated with three doses of VD3 (50 μg/kg) by oral gavage
at 48 h, 24 h, and 1 h before CLP. The doses of VD3 used
in the present study were referred to as others [17] .
Treatment with active VD3
1alpha, 25-dihydroxyvitamin D3 (1alpha, 25(OH)2VD3)
were purchased from Cayman Chemical Co. (Ann
Arbor, MI). Mice were treated with water or 1alpha,
25(OH)2VD3(50μg/kg) for 7 days after CLP by intraperi-
toneal injection.
Assessment of sepsis morbidity
Septic morbidity was evaluated by Murine Sepsis Sever-
ity (MSS) score. Briefly, a score was assigned based on
appearance, level of consciousness, activity, response to
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the stimulus, eyes, respiratory rate, and respiration
quality.
Biochemical analyses
Serum alanine transaminase (ALT) and aspartate amino-
transferase (AST) levels were determined using Vet Test
Chemistry Analyzer (IDEXX) according to the manufac-
turer’s instructions. Serum vitamin D levels were measured
using the vitamin D ELISA kit (#501050, Cayman).
Reverse transcription-quantitative PCR
Total RNA was extracted from ileal tissues by RNAiso
Plus reagent according to the commercial protocol
(TaKaRa, Japan). For each specimen, a total of 500 ng
RNA was reverse-transcribed into cDNA using Prime-
Script RT reagent (TaKaRa, Japan). Quantitative real-
time PCR was performed with Quantstudio 12 K Flex
Real-time PCR system (Life Technologies, Thermo
Fisher Scientific, MA, USA) using primers targeting
Muc1, Muc2, Muc3, Muc4, Cnlp, and β-actin [18–21].
Histology and immunofluorescence
Harvested ileal tissues were washed briefly in cold
phosphate-buffered saline and fixed in Carnoy’s solution
(60% ethanol, 30% chloroform, and 10% glacial acetic
acid) at 4 °C for 4 h. Fixed tissues were stored in 80%
ethanol at 4 °C before tissue processing. Processed sec-
tions were stained with Alcian-blue followed by periodic
acid Schiff reaction. Expression of cathelicidin was de-
tected in a series of ileal specimens harvested in the
acute phase of sepsis. For immunofluorescence, dewaxed
and rehydrated slides of murine ileal sections were
blocked with 10% bovine serum immunofluorescence
buffer (0.1% bovine serum albumin, 0.2% Triton X-100,
0.5% TWEEN 20 in phosphate-buffered saline) and then
incubated with mouse mCRAMP (Santa Cruz,1:200)
antibodies overnight at 4 °C followed by Alexa Fluor
anti-mouse 546 secondary antibodies (1:2000). 4′,6-dia-
midino-2-phenylindole (DAPI) was used for DNA
counterstain. Fluorescent images were captured using a
confocal microscope (Leica).
Apoptosis assay
Apoptosis was assessed by an in situ cell death detection
kit (Roche Applied Science) and confirmed by immuno-
blotting using antibodies targeting caspase-3 and cleaved
caspase-3.
Intestinal permeability assay and tight junction proteins
Mice were gavaged with 4 kD fluorescein isothiocyanate
(FITC)-dextran (500 mg/kg) at 21 h after CLP or sham
surgery. After 3 h, blood was collected and the intensity
of FITC determined by fluorometry. The expression of
tight junction proteins, claudin-1, and occluding was
evaluated by immunoblotting.
Profiling of ileal transcriptome
Total RNA was extracted from ileal tissues at 24 h after
CLP or sham surgery using RNAiso Plus (TaKaRa, Shiga,
Japan). The poly-A RNA was purified and used for
library construction. The sample libraries were se-
quenced with the Illumina HiSeq 2000 sequencing
system (Illumina, San Diego, CA, USA). Clean reads
were aligned to Mus musculus primary DNA index
files (release-94). Transcripts were then assembled by
Cufflinks [22]. Differentially expressed genes (DEGs)
between Cnlp+/+ CLP and Cnlp+/+ Sham mice, as well as
Cnlp−/− CLP and Cnlp−/− Sham mice were identified using
edgeR packages. Short Time-series Expression Miner
(STEM) software was adopted for the identification of co-
expression gene clusters among four groups of mice. The
co-expression pattern of particular gene clusters was con-
firmed and visualized by Pheatmap R package. Pathway
analysis was performed with enrichr R package and visual-
ized by ggplot2. Protein–protein interaction network was
generated in STRING. The interaction between genes was
defined according to “experiments,” “databases,” and “co-
expression.” The network topology was analyzed with the
“NetworkAnalyzer” plugin in cystoscope.
Intestinal epithelial cell isolation
The small intestine was prepared by cutting the gut
about 1 cm downstream from the stomach and 1 cm up-
stream from the cecum. Forceps were used to remove
Peyer’s patches and the attached mesenteric fat carefully.
The small intestine was then placed into a 50mL conical
tube containing 30 mL of CMF HBSS (Hank’s balanced
salt solution with phenol red, Ca2+, and Mg2+-free) with
5% FBS and 2mM EDTA and shook at 250 rpm for 20
min at 37 °C in order to remove epithelial cells and
intraepithelial lymphocytes. The intestine was rapidly
minced and incubated in 20mL of pre-warmed collagenase
solution (1.5mg/mL of collagenase VIII and 40 μg/mL of
DNase I in CMF HBSS/FBS) with a shaking frequency of
200 rpm for 20min at 37 °C for digestion [23].
Flow cytometry
After blocking Fc receptors with anti-mouse CD16/
CD32 (BD Biosciences), small intestinal epithelial cells
were stained with anti-mouse Ly-6G (BioLegend), anti-
mouse F4/80 (BD Biosciences), anti-mouse CD86 (BD
Biosciences), anti-mouse CD206 (BD Biosciences), and
anti-mouse CD45 (BD Biosciences). The stained cells
were analyzed on a FACSCalibur flow cytometer (BD
Biosciences). The data were analyzed using FlowJo Soft-
ware (FlowJo, Ashland, OR). Neutrophils were defined
as Ly6G+ cells and macrophages as F4/80+ cells and M1
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macrophages as F4/80+ CD86+ and M2 macrophages as
F4/80+ CD206+. Lymphocytes were defined as CD45+
cells.
Statistical analysis
Multiple group comparisons were performed by two-
way ANOVA or non-parametric Kruskal-Wallis followed
by the Tukey’s t test. Mortality was compared by
Kaplan-Meier survival curves and analyzed by the log-
rank test. P values less than 0.05 were considered statis-
tically significant.
Results
Endogenous cathelicidin protects against peritonitis-
induced polymicrobial sepsis in mice
Given an increase of mCRAMP mRNA and protein ex-
pression in the ileum of Cnlp+/+ mice following CLP
(Fig. 1a, b), we hypothesized that mCRAMP was an im-
portant peptide in the pathogenesis of sepsis. To ascer-
tain the significance of this antimicrobial peptide during
sepsis, Cnlp−/−, and wild-type mice were included in this
study. All of the mice that underwent sham surgery sur-
vived throughout 7 days (data not shown). Cnlp−/− mice
had increased 7-day mortality (hazard ratio = 2.229, 95%
CI 1.491–7.550) (Fig. 1f) and significantly higher MSS
score (Fig. 1e) and higher level of fluorescein dextran en-
tering the bloodstream upon CLP when compared with
that of Cnlp+/+ mice (Fig. 1c). To ascertain the asso-
ciation between bacterial load and sepsis morbidity and
mortality, total bacterial DNA was determined by
quantitative PCR. Compared to wild-type mice at 24 h
after CLP, Cnlp−/− mice had more than two-fold increase
in bacterial DNA in the blood (Fig. 1d).
Mucin production is reduced in Cnlp−/− mice following
CLP-induced sepsis
Alcian-blue staining demonstrated that the number of
goblet cells per villus in the intestine among the knock-
out group was significantly lower compared with the
wild-type mice (Fig. 2a, b). To further investigate the
underlying mechanisms, we performed real-time quanti-
tative PCR targeting mucin genes Muc1 and Muc2.
Among the Cnlp−/− mice undergone CLP, the expression
levels of Muc2 (Fig. 2c) were significantly reduced as
compared to their wild-type counterparts.
Tight junctions of intestinal epithelial cells were reduced
in septic cathelicidin-knockout mice
To ascertain the reasons for higher gut permeability,
tight junction proteins, namely, occludin and claudin-1,
were determined by immunoblotting. Compared to wild-
type mice at 24 h after CLP, Cnlp−/− mice had lower ex-
pression of occludin and claudin-1 (Fig. 3a, b). Real-time
PCR and transcriptome analysis showed a concordant
downregulation of these two genes at the mRNA level
(data not shown).
Endogenous cathelicidin protects against intestinal
epithelial cell apoptosis in sepsis
To determine the extent of apoptosis in distal ileum
upon experimental sepsis, TUNEL labeling was used. By
24 h after CLP, the number of TUNEL positive punta
per villus increased considerably in both cnlp+/+ and
cnlp−/− mice (Fig. 4s). The depletion of mCRAMP exag-
gerated the magnitude of apoptosis in the distal ileum
by more than three-fold (Fig. 4b). Consistently, cleavage
of caspase-3 was detected in immunoblotting, confirm-
ing active apoptosis (Fig. 4c, d).
Ileal transcriptome identified signaling pathways
regulated by cathelicidin
We performed RNA sequencing to profile the transcrip-
tomes of ileal tissues in the following four groups:
Cnlp+/+ sham, Cnlp+/+ CLP, Cnlp−/− sham, and Cnlp−/−
CLP at 24 h after surgery. STEM analysis identified a
total of 19 significant co-expression gene clusters (Add-
itional file 1: Figure S1), among which 2 co-expression
patterns, i.e., cluster8:1-2-1-4 (Cnlp+/+ Sham-Cnlp+/+
CLP-Cnlp−/− Sham-Cnlp−/− CLP) and cluster16:1-0.5-1-
0.25 appeared to be best correlated to the differences of
MSS scores between groups. In the cluster8, genes were
significantly upregulated after CLP compared with sham
surgery in wide-type mice (2 vs 1). The fold changes of
these genes were further increased (4 vs 1) between CLP
and sham surgery in Cnlp−/− mice. In an inverse pattern,
genes from cluster16 were downregulated by CLP
surgery with a greater extent in Cnlp−/− mice than in
Cnlp+/+ mice. Heatmap analysis further confirmed the
gene expression pattern among groups (Fig. 5a). These
genes were most likely to contribute to the severe septic
symptoms in Cnlp−/− mice compared to wide-type mice.
Then protein–protein interaction network was con-
structed using the genes in cluste8 (Fig. 5b). Topology
analysis identified several “hub” genes with a degree of
16 or higher. Interestingly, these hub genes, e.g., Rac1,
Pak3, Grb2, Stat3, Rela, and Jun, were all reported to
play critical roles in inflammatory signaling (Fig. 5b), im-
plying that dysregulated inflammatory responses might
have aggravated the septic phenotype in Cnlp−/− mice.
Indeed, a series of inflammation-related pathways were
enriched in the KEGG (Kyoto Encyclopedia of Genes
and Genomes; Fig. 5c) and Reactome (Fig. 5d) pathway
analyses.
Deletion of endogenous cathelicidin increases neutrophils
and M1 macrophages in the intestines of septic mice
Flow cytometry revealed that the number of neutrophils
increased by nearly three-fold in wild-type mice 24 h
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after induction of CLP and depletion of Cnlp induced
more neutrophil intestinal infiltration as compared with
the wild-type mice after CLP (Fig. 6a). Moreover, we ob-
served that CLP significantly increased the number of
macrophages in both Cnlp+/+ and Cnlp−/− mice. Com-
pared to wild-type mice at 24 h after CLP, Cnlp−/− mice
had a higher number of macrophages (Fig. 6b). More
specifically, CLP caused a dramatic decline in the
percentage of M1 macrophages and depletion of Cnlp
tended to induce more M1 macrophages compared with
the wild-type mice after CLP (Fig. 6c). In contrast, CLP
significantly increased the percentage of M2 macro-
phages, but knockout of Cnlp had no effect on the num-
ber of M2 macrophages compared with the wild-type
Fig. 1 Murine cathelicidin-related antimicrobial peptide (mCRAMP) is upregulated after cecal-ligation and puncture (CLP) induced sepsis in wild-
type (WT) mice (n = 6 per group) from which total RNA and protein were collected from distal ileum over a period of time for a real-time PCR
and b immunofluorescence for mCRAMP. Genetic knockout (KO) of Cnlp led to f reduced survival and e higher sepsis severity score (n = 18 for
WT mice; n = 17 for KO mice). FITC dextran 4 kD was orally gavaged at 21 h after CLP with serum harvested after 3 h. Genetic KO of Cnlp led to
c increased serum concentration of FITC-labeled dextran 4 kD (FD-4) and d increased bacterial DNA upon experimental sepsis. Error bars denote
standard error of the mean. *P < 0.05; ***P < 0.001; ****P < 0.0001
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Fig. 2 Effects of cecal-ligation and puncture (CLP) or sham surgery (Sham) on acid mucin in distal ileum of cathelicidin wild-type (Cnlp+/+) or
knockout (Cnlp−/−) mice (n = 6 per group) at 24 h after CLP as determined by quantitative real-time PCR and a Alcian blue perioidic acid Schiff
reaction, respectively. b The number of acid-mucin-producing globlet cells per villus and c the expression of mucin genes MUC1 and MUC2 were
compared. Error bars represent standard error of the mean. *P < 0.05; **P < 0.01
Fig. 3 Deletion of Cnlp reduced tight junction of intestinal epithelial cells. The protein levels of a, b occludin and claudin-1 were detected in
cathelicidin-knockout (Cnlp−/−) mice (n = 6) compared to wild-type mice (Cnlp+/+) (n = 6) after CLP-induced sepsis by immunoblotting. Error bars
denote standard error of the mean. ***P < 0.001; ****P < 0.0001
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mice after CLP (Fig. 6d). In addition to neutrophils and
macrophage infiltration, we determined the murine
adaptive immunity after CLP. We showed that CLP did
not promote the migration of lymphocytes into the
ileum at 24 h after CLP (Fig. 7).
Effect of VD3 on peritonitis-induced polymicrobial sepsis
To determine the significance of VD3 in polymicro-
bial sepsis, wild-type mice were divided into two
groups: water CLP group and VD3 CLP group. All
mice underwent CLP pretreated with water or VD3
by gavage at 48, 24, and 1 h before CLP (Fig. 8a).
Mice pretreated with VD3 had decreased 7-day mor-
tality (hazard ratio = 0.223, 95% CI 0.060–0.830)
(Fig. 8b), significantly lower MSS score (Fig. 8c) and
lower levels of fluorescein dextran entering the blood-
stream (Fig. 8d).
Mucin production increased in mice pre-treated with VD3
To further investigate the effect of VD3 on mucin pro-
duction, we performed real-time quantitative PCR tar-
geting mucin genes MUC1–2. Among mice pretreated
with VD3, the expression levels of MUC1 had more than
two-fold increased as compared to mice pretreated with
water (Fig. 8e). However, the expression levels of
MUC2id not vary significantly across the experimental
groups (Fig. 8e).
Fig. 4 Increased apoptosis was detected in cathelicidin-knockout (Cnlp−/−) mice (n = 6) compared to wild-type mice (Cnlp+/+) (n = 6 per group)
after CLP-induced sepsis as demonstrated by a, b TUNEL staining and c, d immunoblotting for cleaved caspase-3. All specimens were collected at
24 h after CLP or Sham surgery. Error bars denote standard error of the mean. **P < 0.01; ***P < 0.001; ****P < 0.0001
Ho et al. Critical Care           (2020) 24:47 Page 7 of 16
Fig. 5 (See legend on next page.)
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VD3 pre-treatment upregulated ileal expression of
cathelicidin in sepsis
To determine the effect of VD3 on the expression of
mCRAMP in distal ileum upon experimental sepsis, im-
munofluorescent staining for mCRAMP was used. By 24
h after CLP, the number of mCRAMP positive punta per
villus increased dramatically compared to mice with
sham surgery (Fig. 9a). Moreover, VD3 pretreatment ex-
aggerated the expression of mCRAMP in the distal ileum
by more than two-fold (Fig. 9a). At the same time, the
result of real-time quantitative PCR revealed a consistent
increase in Cnlp expression at mRNA level (Fig. 9b). Im-
portantly, the VD3-mediated protective effects could not
be observed in CLP mCRAMP-knockout mice (Cnlp−/−)
in terms of murine sepsis score (Fig. 9c) and 7-day
mortality (Fig. 9d).
Effects of inactive and active forms of VD3 on CLP-
induced polymicrobial sepsis
Apart from assessing the prophylactic efficacy of VD3 in
polymicrobial sepsis, we further examined the thera-
peutic potential of VD3 after the onset of sepsis. Results
demonstrated that treatment with VD3 after CLP wors-
ened the mortality (Fig. 10a) and the MSS score
(Fig. 10b) in the CLP model. Possibly, polymicrobial
sepsis resulted in hypoxic hepatitis [24–26]. Under this
pathophysiological condition, enzymatic dysfunctions of
cytochrome p4502R-1 might fail to hydroxylate the in-
active form of vitamin D3 into its intermediate form
(i.e., 25-hydroxyvitamin D3) in the liver [27, 28]. Results
demonstrated that CLP induced hepatic damage as
evidenced by increases in serum ALT and AST levels
(Fig. 10c) and suppression of mRNA expression of
(See figure on previous page.)
Fig. 5 Ileal transcriptomes of septic cathelicidin wild-type and knockout mice. a Heatmap was generated using genes in cluster 8 and cluster 16.
The transcriptome datasets from the septic and non-septic wild-type mice but not the cathelicidin knockout mice were published in Inflamm Res.
2019; 68 [9]:723–726. b Protein-protein interaction network was constructed in STRING using the source of “experiments,” “databases,” and “co-
expression” and visualized by cytoscape. Nodes in round shape have a degree large than 22. Several inflammation-related genes were
highlighted as hub genes according to the topology analysis. c, d Top 30 KEGG and Reactome pathways were plotted. A series of inflammation
related pathways were enriched by both sources
Fig. 6 Deletion of endogenous cathelicidin increased neutrophils and macrophages into small intestine. Effects of CLP or sham surgery on the
relative proportion of neutrophils and macrophages in small intestine of cathelicidin wild-type (Cnlp+/+) or knockout (Cnlp−/−) mice (n = 6 per
group) at 24 h were determined by flow cytometry. a Neutrophils were defined as Ly6G+ cells and b macrophages as F4/80+ cells and c M1
macrophages as F4/80+ CD86+ and d M2 macrophages as F4/80+ CD206+. Error bars denote standard error of the mean. **P < 0.01; ****P < 0.0001
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hepatic cytochrome P450 enzymes CYP2R1 and
CYP27A1 (Fig. 10d), both of which are responsible for
conversions of cholecalciferol (inactive form of VD3)
into 25-hydroxyvitaminD3, eventually resulting in a de-
crease in serum vitamin D3 level (Fig. 10e). To address
this limitation, mice were treated with the active form of
VD3 (i.e., 1alpha, 25(OH)2VD3; calcitriol) that resulted
in better outcomes in terms of 7-day mortality (Fig. 10f),
MSS score (Fig. 10g). and serum VD3 levels (Fig. 10e) in
the CLP model. Taken together, we found that VD3 and
1alpha, 25(OH)2VD3 exerted prophylactic and thera-
peutic effects in a murine polymicrobial sepsis model,
respectively.
Discussion
Cathelicidin is one of the immunomodulatory proteins
involved in the pathogenesis of sepsis [29]. Clinical stud-
ies have shown that human cathelicidin was 50% lower
in critically ill patients with severe sepsis compared to
non-septic patients and was further downregulated in
septic shock [30]. Stratification of critically ill patients by
different levels of plasma cathelicidin revealed that those
with less than 116 ng/mL at admission had four-fold in-
creased risk for 90-day mortality as compared to those
with cathelicidin > 238 ng/mL, after controlling for con-
founders, and also more likely to develop sepsis during
the same hospital stay [31]. These suggest that cathelici-
din has an important role in sepsis.
In this study, we demonstrated that upon induction of
sepsis by CLP in mice, the expression of cathelicidin was
increased by four-fold. The increased expression of this
peptide was more prominent in the first 4 h upon sepsis
induction, indicating that cathelicidin is involved in the
acute phase of sepsis. Instead of a sequential occurrence
of hyper-inflammation or immunosuppression [32], re-
cent studies suggested a paradigm shift in sepsis patho-
genesis in which both processes persist over the course
of the disease, leading to persistent inflammation and ca-
tabolism syndrome [32]. Given the anti-inflammatory
properties of cathelicidin, its gradual decrease at a late
stage after CLP in mice may explain why wild-type mice
would die at a later stage. The protective role of catheli-
cidin was also confirmed in survival analysis between
Cnlp wild-type and knockout group. Consistently, hu-
man cathelicidin protects rats against sepsis after bacter-
ial challenge [33] and the increased expression of
cathelicidin in adipocytes surrounding the colon limits
the release of bacteria from mice with experimental col-
itis [34]. Nevertheless, contradictory evidence also exists
in the literature. Severino et al. reported that wild-type
C57BL/6 mice succumbed more rapidly to CLP com-
pared with cathelicidin-deficient mice [35]. The discrep-
ancies between this report and our study might arise
from the genetic backgrounds of mice (129/SVJ and
C57BL/6, respectively). In this regard, mice of different
genetic backgrounds could exhibit divergent antimicro-
bial activity [36].
Along with the change of cathelicidin expression as re-
vealed by real-time PCR and immunostaining, there
were signs of intestinal barrier dysfunction including
heightened permeability to fluorescein dextran, reduced
mucin production, lowered tight junction protein ex-
pression, and increased apoptotic activity. The bacterial
load in the blood also became higher after the induction
of sepsis. These conditions were further exaggerated in
the cathelicidin-knockout mice, whose survival period
was significantly shortened after CLP. These confirmed
the protective role of cathelicidin in preserving gut
barrier function in sepsis.
Mucins are structural components of mucus, which
lines the gastrointestinal mucosa, and are important in
preventing harmful microbes from entering the blood-
stream [37]. The expression of various mucin genes dif-
fers upon encountering microbial challenges. Of note,
Muc1 is increased considerably after infection [37], a
finding that is in agreement with our observation that
Muc1 and Muc2 genes were upregulated after induction
of experimental sepsis. The magnitude of expression was
reduced after knocking out cathelicidin. Although the
mechanism of cathelicidin in control of mucin produc-
tion remains unclear, the administration of exogenous
cathelicidin to rats has been shown to increase the thick-
ness of the mucus layer in the intestine [38].
Apoptosis and tight junction alterations are important
mechanisms through which intestinal microbes invade
the hosts [39]. In our study, we observed higher activity
of apoptosis after CLP. This was further exaggerated
after knocking out cathelicidin, an antimicrobial peptide
Fig. 7 CLP-induced polymicrobial sepsis did not influence the
lymphocyte count in the ileum (n = 5 for the sham-operated group;
n = 7 for the CLP group). Flow cytometric analysis of lymphocytes
isolated from small intestines of sham-operated or CLP cathelicidin
wild type (Cnlp+/+) was performed. Cells were labeled with anti-
mouse CD45+ lineage surface markers
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that inhibits kidney cell apoptosis by reducing the
endoplasmic reticulum stress [40]. The disruption of gut
barrier integrity may partially explain the higher bacterial
load seen in the cathelicidin-knockout group.
It has been reported that cathelicidin improves septic
mice survival by inhibiting pyroptosis of macrophages
and preventing exaggerated inflammatory responses
[41]. Consistent with this finding, our transcriptome
analysis of ileal tissues revealed that expression of
inflammatory genes (Grb2, Rela, Jun) were shown as the
most popular hub genes (interaction degree large than
20) in the upregulated gene cluster. An increased
intestinal inflammatory response has been shown to be
associated with gut barrier dysfunction in rodents [42].
Collectively, these suggested that cathelicidin depletion
would exaggerate pro-inflammatory response, which was
also verified by the KEGG and Reactome pathway
analyses. Further mechanistic studies will be needed to
determine if cathelicidin controls pro-inflammatory
response via Grb2, Rela, and Jun.
It was demonstrated that human cathelicidin synergis-
tically enhanced the endogenous inflammatory mediator
interleukin-1β and chemokines such as macrophage
chemoattractant proteins in human peripheral blood
Fig. 8 Effect of VD3 on peritonitis-induced polymicrobial sepsis. a All mice (n = 6 per group) underwent CLP surgery pretreated with water or
VD3 by gavage at 48 h, 24 h, and 1 h before CLP. Mice pretreated with VD3 had b decreased 7-day mortality (n = 10 per group) and c significantly
lower MSS score (n = 10 per group) and d lower level of fluorescein dextran entering the bloodstream (n = 6 per group). Mucin production
increased in mice pretreated with VD3. The expression levels of e Muc1 and f Muc2 were detected in mice pretreated with VD3 compared to
mice pretreated with water after CLP-induced sepsis by immunoblotting. Error bars denote standard error of the mean. **P < 0.01;
***P < 0.001; ****P < 0.0001
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mononuclear cells [43]. M1 macrophages can rapidly kill
pathogens to help the primary host defense, which
mainly play a role in pro-inflammation, and M2 macro-
phages routinely repair and maintain tissue integrity,
which serve an anti-inflammatory function [44]. In our
study, we observed a dramatic M1-to-M2 shift in the
small intestine after CLP and depletion of cathelicidin
tended to induce more M1 but not M2 macrophages
compared with the wild-type mice after CLP. So 24 h
after CLP, the immune state of mice seems immunosup-
pressive with macrophages polarizing to an M2 pheno-
type. Given that human cathelicidin directs macrophages
differentiation toward proinflammatory macrophages
[45], depletion of cathelicidin may lower the pro-
inflammation response in the immune environment
during CLP. Apart from modulating the function of
macrophages, cathelicidin can induce the migration of
neutrophils and eosinophils by the formyl-peptide recep-
tor, FPR2 [46]. In our study, CLP induced infiltration of
neutrophils into small intestine and depletion of catheli-
cidin exaggerated neutrophil infiltration compared with
the wild-type mice after CLP. Apart from CLP-induced
infiltration of macrophages and neutrophils, we exam-
ined the infiltration of lymphocytes into the small intes-
tine. Results demonstrated that there is no significant
difference between CLP groups and sham groups. In line
Fig. 9 Pretreatment with VD3 up-regulated the ileal expression of cathelicidin in sepsis. Effect of VD3 on expression of mCRAMP in distal ileum of
wild-type mice at 24 h after CLP were determined by immunofluorescence and (a) real-time quantitative PCR (b). n = 6 per group, error bars
denote standard error of the mean. c, d Prophylactic efficacy of VD3 required cathelicidin in CLP-induced polymicrobial sepsis. Cathelicidin-
knockout mice (Cnlp−/−) pretreated with water or VD3 by oral gavage at 48 h, 24 h, and 1 h before CLP (n = 5 per group). There was no significant
difference between water control and VD3 group in terms of c 7-day mortality as well as d MSS score in Cnlp−/− mice. **P < 0.01; ****P < 0.0001
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with our study, two clinical studies reported that there
were no significant differences in T cell and B cell popu-
lations between septic patients and the corresponding
control group [47, 48]. Collectively, these suggested that
CLP would induce more infiltration of macrophages and
neutrophils into the small intestine. Cathelicidin deple-
tion would exaggerate pro-inflammatory response, which
was associated with elevated production of neutrophils
and M1 macrophages.
Parekh and colleagues analyzed the patient data of 61
patients with sepsis and utilized the CLP model, demon-
strating that sepsis and severe sepsis are associated with
vitamin D deficiency, which in turn is associated with
more severe sepsis [49]. Accumulating evidence suggests
that VD3 exerts protective effects during infections by
up-regulating the expression of cathelicidin and beta-
defensin 2 in phagocytes and epithelial cells [11]. In our
study, we observed that VD3-pretreated mice had better
survival after CLP and these mice also recovered faster
with a better MSS score. Along with increasing of
mucin1 expression, there were signs of upregulation of
cathelicidin with VD3 pretreatment as revealed by real-
time PCR and immunostaining. The bacterial load in
blood became lower in mice after induction of cathelici-
din with VD3. These confirmed that VD3 could up-
regulate the cathelicidin and protect against sepsis.
Furthermore, we assessed the therapeutic use of the
active form and the inactive form of VD3 in our CLP
model. We observed that administration of calcitriol (an
active form of VD3) but not cholecalciferol (an inactive
form of VD3) after the onset of sepsis led to a better
survival outcome in CLP mice. In line with recent
Fig. 10 Effects of inactive and active VD3 after the onset of CLP-induced polymicrobial sepsis. a All mice underwent CLP surgery and were
administered with water or inactive VD3 (50 μg/kg) for one time by oral gavage immediately after CLP (n = 8 per group). Mice treated with
inactive VD3 even had a higher 7-day mortality and b higher day-1 MSS score. CLP-induced polymicrobial sepsis resulted in hepatic damage.
CLP-operated mice demonstrated increased c AST and ALT levels, d decreased CYP2R1 and CYP27A1 mRNA levels, and e reduced serum VD3
levels (intermediate plus active forms) (n = 4–5 per group). For active VD3 treatment, all mice underwent CLP surgery and were administered with
water or active VD3 (50 μg/kg) for 7 days by intraperitoneal injection (n = 11 per group). Mice treated with active VD3 had better outcomes in
terms of f 7-day mortality, g day 2 and day 3 MSS score as well as d higher serum vitamin D3 levels (intermediate plus active forms).*P < 0.05;
**P < 0.01; ***P < 0.001
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publications, high-dose VD3 (cholecalciferol, inactive
form of VD3) did not improve the survival outcomes of
critically ill patients in terms of 90-day mortality [50].
Since hepatic cytochrome P450 (CYPs) play an essential
role in the conversion of VD3 into 25-hydroxyVD3
together with additional evidence showing that hepatic
CYPs dysfunctions are linked to sepsis [51–53], we
further examined the functions of the liver after the on-
set of sepsis. Our results demonstrated that CLP induced
hepatic damage and the associated downregulations of
hepatic CYPs at mRNA level, resulting in decreased
serum intermediate and active VD3. Fortunately, the
administration of calcitriol (an active form of VD3) can
bypass hepatic biotransformation of cholecalciferol into
25-hydroxyVD3 mediated by CYP system, directly enter-
ing the circulatory system and exerting the beneficial ef-
fects. Taken together, we confirmed that the active form
of VD3 but not the inactive form of VD3 is a therapeutic
drug in our CLP model. Noticeably, the latter worsened 7-
day mortality and the associated symptoms in CLP-
operated mice, the mechanism of which remains unclear.
This study has potential limitations. First of all, the
sample size in our survival analyses is relatively small
(n = 8–11). Moreover, only male mice were used for
behavioral studies, considering the lesser influence of
sex hormones on male mice during the estrous cycle.
Our results may not be directly applicable to females.
Last but not the least, no antibiotics were given to the
CLP-operated mice for all experiments, which might
undermine the direct extrapolation of our research find-
ings into the clinical settings.
Conclusion
Cathelicidin is essential in preserving gut barrier func-
tion in sepsis. Replenishment of this protein, its induc-
tion by VD3 or targeting its immediate downstream
molecular moieties may be promising therapies for
sepsis to improve clinical outcomes.
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